Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Learn about the use of Janus kinase inhibitors, which have become promising treatment options for dermatologic conditions such as psoriasis, atopic dermatitis, alopecia areata, vilitigo, and more.
This article reviews the publicly available safety data for brodalumab, an interleukin-17R inhibitor approved for chronic plaque psoriasis. Is its safety profile similar to other IL-17 antagonists?
This review focuses on five major skin conditions for which dietary change may contribute to treatment--both by eliminating "triggers" and providing benefit.
Review new developments in therapy for hereditary angioedema, including new C1 inhibitors, and the development of drugs that target the kallikrein-kinin pathway.
